Three citizens of China entered into an agreement to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd. from BIMI International Medical, Inc. (NasdaqCM:BIMI) on October 24, 2022. The closing of the Agreement is expected to take place late in the fourth quarter of 2022, subject to necessary regulatory approvals.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | +4.55% | +2.22% | -47.49% |
03-05 | Top Premarket Decliners | MT |
01-05 | BIMI International Medical, Inc. Announces Management Appointments | CI |
1st Jan change | Capi. | |
---|---|---|
-47.49% | 15.4M | |
+20.04% | 71.69B | |
-2.10% | 23.65B | |
+9.05% | 9.01B | |
+10.34% | 8.64B | |
-19.68% | 8.15B | |
+13.68% | 5.33B | |
+14.69% | 4.35B | |
-1.04% | 4.1B | |
-2.27% | 3.94B |
- Stock Market
- Equities
- BIMI Stock
- News BIMI Holdings Inc.
- Three citizens of China entered into an agreement to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd. from BIMI International Medical, Inc..